Wall Street Zen upgraded shares of Cigna Group (NYSE:CI – Free Report) from a hold rating to a buy rating in a report published on Sunday,Wall Street Zen reports.
Several other research firms have also recently issued reports on CI. Cantor Fitzgerald reissued an “overweight” rating and issued a $340.00 target price on shares of Cigna Group in a research note on Friday. Guggenheim dropped their price objective on Cigna Group from $361.00 to $347.00 and set a “buy” rating for the company in a report on Friday. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a report on Thursday, August 27th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $337.00 price objective on shares of Cigna Group in a research report on Thursday, October 1st. Finally, Piper Sandler reissued an “overweight” rating on shares of Cigna Group in a research note on Friday, October 23rd. Fourteen equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $335.70.
View Our Latest Analysis on CI
Cigna Group Price Performance
Shares of Cigna Group stock opened at $293.66 on Friday. The firm has a market cap of $77.60 billion, a PE ratio of 12.96, a price-to-earnings-growth ratio of 1.01 and a beta of 0.25. Cigna Group has a 12-month low of $255.53 and a 12-month high of $318.05. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The company’s fifty day simple moving average is $285.81 and its two-hundred day simple moving average is $282.17.
Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.52 by $0.46. The firm had revenue of $73.79 billion for the quarter, compared to analysts’ expectations of $72.64 billion. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. The company’s revenue for the quarter was up 5.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $7.83 earnings per share. As a group, equities analysts expect that Cigna Group will post 30.62 EPS for the current year.
Cigna Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be given a dividend of $1.56 per share. The ex-dividend date is Thursday, December 3rd. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. Cigna Group’s payout ratio is currently 27.54%.
Insider Transactions at Cigna Group
In other Cigna Group news, insider Everett Neville sold 617 shares of the company’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the transaction, the insider owned 5,053 shares in the company, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,677 shares of the stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the transaction, the insider directly owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This represents a 9.37% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Cigna Group
Several hedge funds have recently made changes to their positions in the company. McKinney Capital Management LLC bought a new stake in Cigna Group during the third quarter valued at about $1,373,000. Diversified Trust Co lifted its position in shares of Cigna Group by 42.1% in the third quarter. Diversified Trust Co now owns 4,429 shares of the health services provider’s stock valued at $1,204,000 after acquiring an additional 1,313 shares in the last quarter. Vista Capital Partners Inc. bought a new position in shares of Cigna Group in the third quarter worth about $332,000. Aberdeen Group plc boosted its stake in shares of Cigna Group by 389.6% in the third quarter. Aberdeen Group plc now owns 1,078,857 shares of the health services provider’s stock worth $283,907,000 after acquiring an additional 858,488 shares during the period. Finally, Allworth Financial LP grew its position in shares of Cigna Group by 7.5% during the third quarter. Allworth Financial LP now owns 34,925 shares of the health services provider’s stock worth $9,628,000 after purchasing an additional 2,444 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.
Cigna Group News Summary
Here are the key news stories impacting Cigna Group this week:
- Positive Sentiment: Third-quarter adjusted earnings were $7.98 per share, ahead of estimates, while revenue rose 6% to about $73.8 billion and also exceeded consensus. Strength in Cigna Healthcare and a favorable pharmacy benefit mix supported results. Cigna Q3 Earnings and Revenues Beat Estimates
- Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share. Employer medical growth is expected to help offset Cigna’s exit from the ACA individual market. Cigna lifts 2026 outlook
- Positive Sentiment: At its investor event, Cigna outlined a multi-year $3 billion modernization and productivity program, targeting 10%–14% adjusted EPS growth annually and approximately $50 billion in cumulative operating cash flow through 2030. Cigna raises 2026 outlook after strong quarter
- Neutral Sentiment: Analyst views remain supportive: Cantor Fitzgerald reaffirmed Overweight with a $340 target. Guggenheim kept a Buy rating but lowered its target to $347 from $361, tempering the positive signal. Guggenheim ratings
- Negative Sentiment: Despite higher adjusted earnings, reported GAAP net income fell to $1.4 billion from $1.87 billion a year earlier. The ACA individual-market exit also brings transition and execution risks, even as employer business growth is expected to offset it. Cigna Group lifts outlook as revenue climbs
Cigna Group Company Profile
The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members.
Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.
The company serves customers in the United States and select international markets.
Read More
- Five stocks we like better than Cigna Group
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
- After the Midterms, Which of These 3 Defense ETFs Looks Strongest?
- The Ugly Truth Behind SoundHound’s Q3 Results
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
